Entrada Therapeutics, Inc. Profile Avatar - Palmy Investing

Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and e…

Biotechnology
US, Boston [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of TRDA's Analysis
CIK: 1689375 CUSIP: 29384C108 ISIN: US29384C1080 LEI: - UEI: -
Secondary Listings
TRDA has no secondary listings inside our databases.